LIMNW vs NSC
Liminatus Pharma, Inc. Warrants (LIMNW) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
LIMNW does not have a complete income-statement cache yet.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
LIMNW currently screens at market cap $0. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the LIMNW and NSC stock pages for the full models.
Not investment advice.